Cogent Biosciences to present GIST trial data at ASCO meeting

April 21, 2026 8:01 AM

Cogent Biosciences Inc. (NASDAQ: COGT) announced that results from its Phase 3 PEAK trial will be presented at the 2026 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found